The cryo-EM structure of the human uromodulin filament core reveals a unique assembly mechanism

  1. Jessica J Stanisich
  2. Dawid S Zyla
  3. Pavel Afanasyev
  4. Jingwei Xu
  5. Anne Kipp
  6. Eric Olinger
  7. Olivier Devuyst
  8. Martin Pilhofer
  9. Daniel Boehringer
  10. Rudi Glockshuber  Is a corresponding author
  1. Institute of Molecular Biology and Biophysics, Swiss Federal Institute of Technology, Switzerland
  2. Swiss Federal Institute of Technology, Switzerland
  3. University of Zurich, Switzerland
  4. Newcastle University, United Kingdom
  5. ETH Zürich, Switzerland

Abstract

The glycoprotein uromodulin (UMOD) is the most abundant protein in human urine and forms filamentous homopolymers that encapsulate and aggregate uropathogens, promoting pathogen clearance by urine excretion. Despite its critical role in the innate immune response against urinary tract infections, the structural basis and mechanism of UMOD polymerization remained unknown. Here, we present the cryo-EM structure of the UMOD filament core at 3.5 Å resolution, comprised of the bipartite zona pellucida (ZP) module in a helical arrangement with a rise of ~65 Å and a twist of ~180°. The immunoglobulin-like ZPN and ZPC subdomains of each monomer are separated by a long linker that interacts with the preceding ZPC and following ZPN subdomains by β-sheet complementation. The unique filament architecture suggests an assembly mechanism in which subunit incorporation could be synchronized with proteolytic cleavage of the C-terminal pro-peptide that anchors assembly-incompetent UMOD precursors to the membrane.

Data availability

Structures and maps presented in this paper have been deposited to the Protein Data Bank (PDB) and Electron Microscopy Data Base (EMDB) with the following accession codes: 3.5 Å cryoSPARC map EMD-11388, the UMOD AU model PDB ID: 6ZS5, elongated model of UMOD filament derived from cryoSPARC map PDB ID: 6ZYA, 4.7 Å cisTEM map EMD-11471.

The following data sets were generated
The following previously published data sets were used
    1. Karczewski KJ et al
    (2020) Genome Aggregation Database (GnomAD)
    Genome Aggregation Database (GnomAD) v2.1.1, GRCh37.

Article and author information

Author details

  1. Jessica J Stanisich

    Biology, Institute of Molecular Biology and Biophysics, Swiss Federal Institute of Technology, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2702-8092
  2. Dawid S Zyla

    Biology, Institute of Molecular Biology and Biophysics, Swiss Federal Institute of Technology, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8471-469X
  3. Pavel Afanasyev

    Cryo-EM Knowledge Hub (CEMK), Swiss Federal Institute of Technology, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  4. Jingwei Xu

    Biology, Institute of Molecular Biology and Biophysics, Swiss Federal Institute of Technology, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  5. Anne Kipp

    Institute of Physiology, University of Zurich, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  6. Eric Olinger

    Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1178-7980
  7. Olivier Devuyst

    Institute of Physiology, Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3744-4767
  8. Martin Pilhofer

    Biology, Institute of Molecular Biology and Biophysics, Swiss Federal Institute of Technology, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3649-3340
  9. Daniel Boehringer

    Institute for Molecular Biology and Biophysics, ETH Zürich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  10. Rudi Glockshuber

    Biology, Institute of Molecular Biology and Biophysics, Swiss Federal Institute of Technology, Zurich, Switzerland
    For correspondence
    rudi@mol.biol.ethz.ch
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3320-3843

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030B_176403/1)

  • Rudi Glockshuber

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_156304)

  • Rudi Glockshuber

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_179255)

  • Martin Pilhofer

H2020 European Research Council (679209)

  • Martin Pilhofer

NOMIS Stiftung (n/a)

  • Martin Pilhofer

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_189044)

  • Olivier Devuyst

Swiss National Centre of Competence in Research Kidney Control of Homeostasis (n/a)

  • Olivier Devuyst

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2ZHP3_195181)

  • Eric Olinger

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The use of human urine samples for UMOD purification was approved by the Ethical Committee of the UCLouvain Medical School in Brussels, Belgium (Project EUNEFRON, 2011/04May/184). All individuals gave written informed consent.The completed "Consent form for publication in eLife" has been filed on the donor's behalf.

Copyright

© 2020, Stanisich et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,344
    views
  • 613
    downloads
  • 31
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jessica J Stanisich
  2. Dawid S Zyla
  3. Pavel Afanasyev
  4. Jingwei Xu
  5. Anne Kipp
  6. Eric Olinger
  7. Olivier Devuyst
  8. Martin Pilhofer
  9. Daniel Boehringer
  10. Rudi Glockshuber
(2020)
The cryo-EM structure of the human uromodulin filament core reveals a unique assembly mechanism
eLife 9:e60265.
https://doi.org/10.7554/eLife.60265

Share this article

https://doi.org/10.7554/eLife.60265

Further reading

    1. Structural Biology and Molecular Biophysics
    Jinsai Shang, Douglas J Kojetin
    Research Advance

    Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor transcription factor that regulates gene expression programs in response to ligand binding. Endogenous and synthetic ligands, including covalent antagonist inhibitors GW9662 and T0070907, are thought to compete for the orthosteric pocket in the ligand-binding domain (LBD). However, we previously showed that synthetic PPARγ ligands can cooperatively cobind with and reposition a bound endogenous orthosteric ligand to an alternate site, synergistically regulating PPARγ structure and function (Shang et al., 2018). Here, we reveal the structural mechanism of cobinding between a synthetic covalent antagonist inhibitor with other synthetic ligands. Biochemical and NMR data show that covalent inhibitors weaken—but do not prevent—the binding of other ligands via an allosteric mechanism, rather than direct ligand clashing, by shifting the LBD ensemble toward a transcriptionally repressive conformation, which structurally clashes with orthosteric ligand binding. Crystal structures reveal different cobinding mechanisms including alternate site binding to unexpectedly adopting an orthosteric binding mode by altering the covalent inhibitor binding pose. Our findings highlight the significant flexibility of the PPARγ orthosteric pocket, its ability to accommodate multiple ligands, and demonstrate that GW9662 and T0070907 should not be used as chemical tools to inhibit ligand binding to PPARγ.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.